IIQ vs NYR

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IIQ

INOVIQ LTD FPO [IIQ]

52MEDIUM

NYR

NYRADA CDI FORUS [NYR]

52MEDIUM

Score Breakdown

IIQ NYR
Technical
33
72
Catalyst
55
53
Sentiment
50
50
Fundamental
77
38
Momentum
49
71
Risk Gate
50
42

Key Metrics

IIQ Metric NYR
$46.5MMarket Cap$134.7M
154KAvg Volume (20d)545K
N/AShort InterestN/A
$0.69052-Week High$1.435
$0.31552-Week Low$0.091
+0.0%Daily Change+16.9%
$0.330Entry Price$0.567
-34.7%ROE-71.0%
N/AProfit Margin-234.3%

Active Signals

IIQ Signals

Trading below both moving averages — the trend is working against this one
Drifting lower — down 7.0% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (11 quarters)
4C filed 2026-01-28
Strong revenue growth (+35%)
EPS estimates revised downward (-6pts)
Near 52-week low (4% of range)

NYR Signals

MACD momentum is picking up steam
Stochastic just turned bullish from a low level — early reversal sign
Watch out — volume is flowing out even as price holds up. Distribution pattern
On a tear — up 12.3% over the last 5 days
Trading above the 200-day average — the long-term trend is on your side
Low cash runway (4 quarters) - dilution risk
Very high P/S ratio (56.6x)
Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare IIQ and NYR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IIQ Full Analysis → NYR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).